title: American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.
authors.affiliation: Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: K Rajender
authors.initials: KR
authors.lastname: Reddy
authors.affiliation: Division of Gastroenterology and Hepatology, Medical University of South Carolina, Charleston, South Carolina.
authors.forename: Kimberly L
authors.initials: KL
authors.lastname: Beavers
authors.affiliation: Division of Infectious Diseases, Brigham & Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
authors.forename: Sarah P
authors.initials: SP
authors.lastname: Hammond
authors.affiliation: Division of Gastroenterology and Hepatology, Yale University School of Medicine, New Haven, Connecticut.
authors.forename: Joseph K
authors.initials: JK
authors.lastname: Lim
authors.affiliation: Division of Gastroenterology and Hepatology, Department of Medicine, Case and VA Medical Center, Case Western Reserve University, Cleveland, Ohio.
authors.forename: Yngve T
authors.initials: YT
authors.lastname: Falck-Ytter
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D004279:DNA, Viral / Q000097:blood; D006509:Hepatitis B / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D006510:Hepatitis B Antibodies / Q000097:blood; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000187:drug effects* / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D012008:Recurrence; D016896:Treatment Outcome; D019562:Viral Load; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents; D015415:Biomarkers; D004279:DNA, Viral; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D007166:Immunosuppressive Agents